Physicochemical Properties
| Molecular Formula | C10H20N5NA2O16P3 |
| Molecular Weight | 605.19 |
| Exact Mass | 550.959 |
| Elemental Analysis | C, 19.85; H, 3.33; N, 11.57; Na, 7.60; O, 42.30; P, 15.35 |
| CAS # | 51963-61-2 |
| Related CAS # | ATP disodium salt;987-65-5;ATP;56-65-5;ATP dimagnesium;74804-12-9;ATP disodium salt hydrate;34369-07-8;ATP dipotassium;42373-41-1;ATP ditromethamine;102047-34-7;ATP-13C dilithium;ATP-15N5,d14 dilithium;ATP-d14 dilithium;ATP-15N5 dilithium;ATP-13C10 dilithium |
| PubChem CID | 22799238 |
| Appearance | White to off-white solid powder |
| Melting Point | 176ºC |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 35 |
| Complexity | 772 |
| Defined Atom Stereocenter Count | 4 |
| SMILES | C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O)N.[Na+].[Na+].[Na+].[Na+] |
| InChi Key | MWEQTWJABOLLOS-AZGWGOJFSA-L |
| InChi Code | InChI=1S/C10H16N5O13P3.2Na.3H2O/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20;;;;;/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20);;;3*1H2/q;2*+1;;;/p-2/t4-,6-,7-,10-;;;;;/m1...../s1 |
| Chemical Name | disodium;[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] hydrogen phosphate;trihydrate |
| Synonyms | 51963-61-2; ADENOSINE 5'-TRIPHOSPHATE DISODIUM SALT TRIHYDRATE; Adenosine 5'-(tetrahydrogen triphosphate), disodium salt, trihydrate; disodium;[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-oxidophosphoryl] hydrogen phosphate;trihydrate; Adenosine triphosphate disodium salt; Adenosine 5'-triphosphate disodium salt; sodium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogentriphosphate trihydrate; Adenosine-5'-triphosphate disodium salt trihydrate; |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | Human Endogenous Metabolite; P2X7 receptor |
| ln Vitro |
The activation of the NLRP3 inflammasome in HGFs is enhanced when ATP disodium trihydrate (5 mM; 1 hour) and LPS (1 μg/mL) are treated together [3]. In a manner that is dependent on caspase-1 activation, ATP disodium trihydrate (2 mM; 0.5-24 hours) causes BMDM to release KC, MIP-2, and IL-1β [4]. Chemotaxis of neutrophils is facilitated by ATP disodium trihydrate [4]. - Cytokine release modulation: Adenosine-5'-Triphosphate (ATP) at concentrations of 10–100 μM significantly enhanced lipopolysaccharide (LPS)-induced interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) release in stimulated whole blood. This effect was abrogated by P2X7 receptor antagonists, indicating P2X7-mediated signaling [1]. - NLRP3 inflammasome activation: In human gingival fibroblasts, ATP (5 mM) co-administered with Porphyromonas gingivalis LPS triggered NLRP3 inflammasome activation, as evidenced by caspase-1 cleavage and IL-1β secretion. This process was inhibited by doxycycline [3]. |
| ln Vivo |
In vivo, mice are protected against bacterial infection by ATP disodium trihydrate (50 mg/kg; ip) [4]. In vivo, ATP disodium trihydrate stimulates the release of KC, MIP-2, and IL-1β as well as the recruitment of neutrophils [4]. - Bacterial infection protection: Intraperitoneal injection of ATP (20 mg/kg) in mice significantly improved survival rates (60% vs. 20% in control) and reduced bacterial burden in a peritoneal Escherichia coli infection model. Protection was abolished in NLRP3 knockout mice, confirming NLRP3-dependent mechanism [4]. |
| Cell Assay |
- Whole blood stimulation: Human whole blood was incubated with LPS (1 μg/mL) and ATP (10–100 μM) for 6 hours. Cytokine levels in supernatants were measured by enzyme-linked immunosorbent assay (ELISA). P2X7 antagonist oxidized ATP (100 μM) blocked ATP-induced cytokine release [1]. - Gingival fibroblast stimulation: Human gingival fibroblasts were primed with LPS (1 μg/mL) for 3 hours, followed by ATP (5 mM) treatment for 30 minutes. Cell lysates were analyzed by Western blot for caspase-1 p20 and IL-1β, while supernatants were assayed for secreted IL-1β [3]. |
| Animal Protocol |
Animal/Disease Models: Fourweeks old Kunming mice (18-22 g)[4] Doses: 50 mg/kg Route of Administration: intraperitoneal (ip)injection, before bacterial (E. coli) challenge Experimental Results: Protected mice from bacterial infection. - Mouse infection model: ATP was dissolved in sterile saline and administered intraperitoneally (20 mg/kg) to C57BL/6 mice 1 hour before intraperitoneal injection of E. coli (1×10⁹ CFU). Survival was monitored for 72 hours, and peritoneal lavage fluid was cultured to quantify bacterial counts [4]. |
| References |
[1]. Immunoregulatory effects of adenosine 5'-triphosphate on cytokine release from stimulated whole blood. Eur J Immunol. 2005 Mar;35(3):852-8. [2]. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006 Nov;112(2):358-404. [3]. Doxycycline inhibits NAcht Leucine-rich repeat Protein 3 inflammasome activation and interleukin-1β production induced by Porphyromonas gingivalis-lipopolysaccharide and adenosine triphosphate in human gingival fibroblasts. Arch Oral Biol. 2019 Nov;107:104514. [4]. Adenosine-5'-Triphosphate (ATP) Protects Mice against Bacterial Infection by Activation of the NLRP3 Inflammasome. PLoS One. 2013; 8(5): e63759. |
| Additional Infomation |
- Mechanism of action: ATP acts as a danger-associated molecular pattern (DAMP) to activate P2X7 receptors, leading to potassium efflux and NLRP3 inflammasome assembly. This promotes caspase-1 activation and IL-1β/IL-18 secretion, enhancing host defense against bacterial infection [2, 4]. - Immunomodulatory role: Extracellular ATP can either promote inflammation via P2X7 signaling or suppress it through adenosine-mediated pathways, depending on local concentration and cell context [2]. |
Solubility Data
| Solubility (In Vitro) |
H2O :~250 mg/mL (~413.09 mM) DMSO :~1 mg/mL (~1.65 mM (<80°C)) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (82.62 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication (<60°C).  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.6524 mL | 8.2619 mL | 16.5237 mL | |
| 5 mM | 0.3305 mL | 1.6524 mL | 3.3047 mL | |
| 10 mM | 0.1652 mL | 0.8262 mL | 1.6524 mL |